- Learning Objective 1: Understand the newborn screen process for cystic fibrosis (CF) and the role of the pediatrician
- Learning Objective 2: Provide an update on the current state of CF treatments, outcomes and life expectancy
- Learning Objective 3: Introduce the new genetic modulator drugs that target the basic defect in CF
Session date:
01/04/2024 - 12:00pm to 1:00pm CST
Location:
P-117
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Kimberly Watts, MD, MSc